Last updated on November 2006

Efficacy of Retreatments With Intravitreal Bevacizumab


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Choroidal Neovascularization | Age Related Macular Degeneration
  • Age: Between 60 - 95 Years
  • Gender: Male or Female
  • Other:
    * Any visual acuity
    OCT: Central foveal thickness greater than 300 u or with evidence of subretinal
    fluid.
    Active angiogram leakage

You may not be eligible for this study if the following are true:

  • * Basal Inflammatory disease
    Endoftalmitis history
    Lesions bigger than 5400 u or with scarring greater than 50% of lesion.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.